Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 320

1.

SPARC is expressed in human uveal melanoma and its abrogation reduces tumor cell proliferation.

Maloney SC, Marshall JC, Antecka E, Orellana ME, Fernandes BF, Martins C, Castiglione E, DI Cesare S, Logan P, Burnier MN Jr.

Anticancer Res. 2009 Aug;29(8):3059-64.

2.

Expression of nm23-H1 in uveal melanoma.

Bakalian S, Marshall JC, Faingold D, Logan P, Antecka E, Burnier MN Jr.

Melanoma Res. 2007 Oct;17(5):284-90.

PMID:
17885583
3.

Bone morphogenetic protein 7 inhibits tumor growth of human uveal melanoma in vivo.

Notting I, Buijs J, Mintardjo R, van der Horst G, Vukicevic S, Lowik C, Schalij-Delfos N, Keunen J, van der Pluijm G.

Invest Ophthalmol Vis Sci. 2007 Nov;48(11):4882-9.

PMID:
17962434
4.

Activation of the FGF2/FGFR1 autocrine loop for cell proliferation and survival in uveal melanoma cells.

Lefèvre G, Babchia N, Calipel A, Mouriaux F, Faussat AM, Mrzyk S, Mascarelli F.

Invest Ophthalmol Vis Sci. 2009 Mar;50(3):1047-57. doi: 10.1167/iovs.08-2378. Epub 2008 Nov 21.

PMID:
19029025
5.

Characterizing the involvement of the nuclear factor-kappa B (NF kappa B) transcription factor in uveal melanoma.

Dror R, Lederman M, Umezawa K, Barak V, Pe'er J, Chowers I.

Invest Ophthalmol Vis Sci. 2010 Apr;51(4):1811-6. doi: 10.1167/iovs.09-3392. Epub 2009 Nov 5.

PMID:
19892878
6.

Differential expression of chemokine receptors on uveal melanoma cells and their metastases.

Li H, Alizadeh H, Niederkorn JY.

Invest Ophthalmol Vis Sci. 2008 Feb;49(2):636-43. doi: 10.1167/iovs.07-1035.

PMID:
18235009
7.

Expression of the SST receptor 2 in uveal melanoma is not a prognostic marker.

Kouch-el Filali M, Kilic E, Melis M, de Klein A, de Jong M, Luyten GP.

Graefes Arch Clin Exp Ophthalmol. 2008 Nov;246(11):1585-92. doi: 10.1007/s00417-008-0880-x. Epub 2008 Aug 6.

PMID:
18682975
8.

Expression of the metastasis suppressor gene KISS1 in uveal melanoma.

Martins CM, Fernandes BF, Antecka E, Di Cesare S, Mansure JJ, Marshall JC, Burnier MN Jr.

Eye (Lond). 2008 May;22(5):707-11. doi: 10.1038/sj.eye.6703090. Epub 2008 Jan 25.

PMID:
18219339
9.

Silencing of secreted protein acidic and rich in cysteine inhibits the growth of human melanoma cells with G arrest induction.

Horie K, Tsuchihara M, Nakatsura T.

Cancer Sci. 2010 Apr;101(4):913-9. doi: 10.1111/j.1349-7006.2009.01476.x. Epub 2009 Dec 16.

10.

Transcriptional profiling of human uveal melanoma from cell lines to intraocular tumors to metastasis.

Marshall JC, Nantel A, Blanco P, Ash J, Cruess SR, Burnier MN Jr.

Clin Exp Metastasis. 2007;24(5):353-62. Epub 2007 May 9.

PMID:
17487557
11.

Angiogenic profile of uveal melanoma.

Notting IC, Missotten GS, Sijmons B, Boonman ZF, Keunen JE, van der Pluijm G.

Curr Eye Res. 2006 Sep;31(9):775-85.

PMID:
16966150
12.

MicroRNA-34a inhibits uveal melanoma cell proliferation and migration through downregulation of c-Met.

Yan D, Zhou X, Chen X, Hu DN, Dong XD, Wang J, Lu F, Tu L, Qu J.

Invest Ophthalmol Vis Sci. 2009 Apr;50(4):1559-65. doi: 10.1167/iovs.08-2681. Epub 2008 Nov 21.

PMID:
19029026
13.

The p53/p21Cip1/ Waf1 pathway mediates the effects of SPARC on melanoma cell cycle progression.

Fenouille N, Robert G, Tichet M, Puissant A, Dufies M, Rocchi S, Ortonne JP, Deckert M, Ballotti R, Tartare-Deckert S.

Pigment Cell Melanoma Res. 2011 Feb;24(1):219-32. doi: 10.1111/j.1755-148X.2010.00790.x. Epub 2010 Nov 17.

PMID:
20955243
14.

Downregulation of SPARC expression decreases gastric cancer cellular invasion and survival.

Yin J, Chen G, Liu Y, Liu S, Wang P, Wan Y, Wang X, Zhu J, Gao H.

J Exp Clin Cancer Res. 2010 Jun 2;29:59. doi: 10.1186/1756-9966-29-59.

15.

Melatonin receptors in human uveal melanocytes and melanoma cells.

Roberts JE, Wiechmann AF, Hu DN.

J Pineal Res. 2000 Apr;28(3):165-71.

PMID:
10739303
16.

Inhibitor of apoptosis proteins gene expression and its correlation with prognostic factors in primary and metastatic uveal melanoma.

Lederman M, Meir T, Zeschnigk M, Pe'er J, Chowers I.

Curr Eye Res. 2008 Oct;33(10):876-84. doi: 10.1080/02713680802382989.

PMID:
18853322
17.

Small interfering RNA inhibition of SPARC attenuates the profibrotic effect of transforming growth factor beta1 in cultured normal human fibroblasts.

Zhou X, Tan FK, Guo X, Wallis D, Milewicz DM, Xue S, Arnett FC.

Arthritis Rheum. 2005 Jan;52(1):257-61.

18.

Status of RASSF1A in uveal melanocytes and melanoma cells.

Calipel A, Abonnet V, Nicole O, Mascarelli F, Coupland SE, Damato B, Mouriaux F.

Mol Cancer Res. 2011 Sep;9(9):1187-98. doi: 10.1158/1541-7786.MCR-10-0437. Epub 2011 Jul 25.

19.

Suppression of SPARC expression by antisense RNA abrogates the tumorigenicity of human melanoma cells.

Ledda MF, Adris S, Bravo AI, Kairiyama C, Bover L, Chernajovsky Y, Mordoh J, Podhajcer OL.

Nat Med. 1997 Feb;3(2):171-6.

PMID:
9018235
20.

c-Kit-dependent growth of uveal melanoma cells: a potential therapeutic target?

All-Ericsson C, Girnita L, Müller-Brunotte A, Brodin B, Seregard S, Ostman A, Larsson O.

Invest Ophthalmol Vis Sci. 2004 Jul;45(7):2075-82.

PMID:
15223779
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk